Growing number of clinical trials in the field of cancer therapies is augment the growth of the Immuno oncology assays market
The immuno-oncology assays are valuable tools in the fight against cancer. These newest methods help to determine how new drugs will interact with existing products and agents, researchers and doctors can design preventative drug plans and better target the treatment of malignant tumors. These assays have been developed to measure the ability of tumor cells to resist various viruses, bacteria, chemicals, and pesticides. These assays are important for both research and pre-clinical development of vaccines, medicines, and drugs. The rising prevalence of cancer around the globe is a prime factor driving the growth of the immuno oncology assays market. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. The immuno-oncology assay is widely used in clinical trials because it helps in reducing the cost of research and also improve...